Company

Sun Genomics, Inc.

Sun Genomics, Inc. makes personalized probiotics for gut health, based on microbiome testing and health surveys.

About

Sun Genomics sells Floré personalized probiotics, formulated from individual microbiome test results and health surveys, in capsule and powder forms, on a subscription model. Founded in 2016 and based in San Diego, US, the company is led by founder and CEO Suneer Jain. It raised USD 9.25 mn in Series A funding led by Pangaea Ventures in September 2020.

6Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in